文献速递流行病学与生物统计临床试验与 GCP

社区队列研究:二尖瓣反流的结局与治疗不足

Outcome and undertreatment of mitral regurgitation: a community cohort study.
PubMed 文献 · Lancet · 2018-01-01

该研究基于美国奥姆斯特德县社区队列,纳入2000至2010年诊断的1294例中重度孤立性二尖瓣反流患者,发现其死亡率显著高于预期,心力衰竭常见,但仅15%接受二尖瓣手术,提示治疗不足。

要点

  • 仅15%患者接受二尖瓣手术,5年心力衰竭发生率达64%。

核心结论

  • 社区中孤立性二尖瓣反流常见,与超额死亡和频繁心力衰竭相关,但治疗不足。

研究设计与样本

  • 观察性队列研究,使用Mayo Clinic电子健康记录和Rochester Epidemiology Project识别2000-2010年Olmsted县诊断的中重度孤立性二尖瓣反流患者1294例。

主要发现

  • 中位诊断年龄77岁,左室射血分数低于50%者538例(42%)。
  • 5年心力衰竭发生率平均64%(SE 1),射血分数≥50%者49%(SE 2),原发性反流者48%(SE 2)。

关键数值与推荐

  • 二尖瓣手术仅198例(15%),其中瓣膜修复149例(75%)。
  • 射血分数低于50%者手术28例(5%),射血分数≥50%者170例(22%)。
  • 继发性二尖瓣反流手术34例(5%),原发性164例(29%)。

临床怎么用

  • 社区中重度二尖瓣反流患者即使射血分数正常或合并症少,死亡和心衰风险仍高,应考虑更积极评估手术指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral regurgitation is the most common valve disease worldwide but whether the community-wide prevalence, poor patient outcomes, and low rates of surgical treatment justify costly development of new therapeutic interventions remains uncertain. Therefore, we did an observational cohort study to assess the clinical characteristics, outcomes, and degree of undertreatment of mitral regurgitation in a community setting. METHODS: We used data from Mayo Clinic electronic health records and the Rochester Epidemiology Project to identify all cases of moderate or severe isolated single-valvular mitral regurgitation (with no other severe left-sided valvular disease or previous mitral surgery) diagnosed during a 10-year period in the community setting in Olmsted County (MN, USA). We assessed clinical characteristics, mortality, heart failure incidence, and results of cardiac surgery post-diagnosis. FINDINGS: Between Jan 1, 2000, and Dec 31, 2010, 1294 community residents (median age at diagnosis 77 years [IQR 66-84]) were diagnosed with moderate or severe mitral regurgitation by Doppler echocardiography (prevalence 0·46% [95% CI 0·42-0·49] overall; 0·59% [0·54-0·64] in adults). Left-ventricular ejection fraction below 50% was frequent (recorded in 538 [42%] patients), and these patients had a slightly lower regurgitant volume than those with an ejection fraction of 50% or higher (mean 39 mL [SD 16] vs 45 mL [21], p<0·0001). Post-diagnosis mortality was mainly cardiovascular in nature (in 420 [51%] of 824 patients for whom the cause of death was available) and higher than expected for residents of the county for age or sex (risk ratio [RR] 2·23 [95% CI 2·06-2·41], p<0·0001). This excess mortality affected all subsets of patients, whether they had a left-ventricular ejection fraction lower than 50% (RR 3·17 [95% CI 2·84-3·53], p<0·0001) or of 50% or higher (1·71 [1·53 -1·91], p<0·0001) and with primary mitral regurgitation (RR 1·73 [95% CI 1·53-1·96], p<0·0001) or secondary mitral regurgitation (2·72 [2·48-3·01], p<0·0001). Even patients with a low comorbidity burden combined with favourable characteristics such as left-ventricular ejection fraction of 50% or higher (RR 1·28 [95% CI 1·10-1·50], p<0·0017) or primary mitral regurgitation (1·29 [1·09-1·52], p=0·0030) incurred excess mortality. Heart failure was frequent (mean 64% [SE 1] at 5 years postdiagnosis), even in patients with left-ventricular ejection fraction of 50% or higher (49% [2] at 5 years postdiagnosis) or in those with primary mitral regurgitation (48% [2]). Mitral surgery was ultimately done in only 198 (15%) of 1294 patients, of which the predominant type of surgery was valve repair (in 149 [75%] patients). Mitral surgery was done in 28 (5%) of 538 patients with left-ventricular ejection fraction below 50% and in 170 (22%) of 756 patients with ejection fraction of 50% or higher, and in 34 (5%) of 723 with secondary mitral regurgitation versus 164 (29%) of 571 with primary regurgitation. All other types of cardiac surgery combined were performed in only 3% more patients (237 [18%] patients) than the number who underwent mitral surgery. INTERPRETATION: In the community, isolated mitral regurgitation is common and is associated with excess mortality and frequent heart failure postdiagnosis in all patient subsets, even in those with normal left-ventricular ejection fraction and low comorbidity. Despite these poor outcomes, only a minority of affected patients undergo mitral (or any type of cardiac) surgery even in a community with all means of diagnosis and treatment readily available and accessible. This suggests that in a wider population there might be a substantial unmet need for treatment for this disorder. FUNDING: Mayo Clinic Foundation.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018. PMID: 29536860. doi:10.1016/S0140-6736(18)30473-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。